RDNT logo

RadNet, Inc. Stock Price

NasdaqGM:RDNT Community·US$4.4b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author

RDNT Share Price Performance

US$58.16
0.29 (0.50%)
US$89.75
Fair Value
US$58.16
0.29 (0.50%)
35.2% undervalued intrinsic discount
US$89.75
Fair Value
Price US$58.16
AnalystConsensusTarget US$89.75

RDNT Community Narratives

·
Fair Value US$89.75 35.2% undervalued intrinsic discount

RDNT: Imaging Center Demand And Digital Health Will Drive Measured Upside Potential

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Trending Discussion

Updated Narratives

RDNT logo

RDNT: Advanced Imaging And AI Execution Will Support Future Earnings

Fair Value: US$89.75 35.2% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with reasonable growth potential.

2 Risks
3 Rewards

RadNet, Inc. Key Details

US$2.1b

Revenue

US$1.8b

Cost of Revenue

US$368.9m

Gross Profit

US$383.1m

Other Expenses

-US$14.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.18
17.20%
-0.66%
80.3%
View Full Analysis

About RDNT

Founded
1981
Employees
9060
CEO
Howard Berger
WebsiteView website
www.radnet.com

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Recent RDNT News & Updates

Narrative Update Jun 06

RDNT: Advanced Imaging And AI Execution Will Support Future Earnings

Narrative Update: RadNet The updated analyst price target for RadNet has shifted modestly lower to around $90 per share. This reflects analysts’ recalibration of fair value and discount rate assumptions, while also acknowledging continuing support from recent research that highlights the stock’s inclusion in high-conviction lists and its relative strength in advanced volume growth and imaging pricing versus peers.
Analysis Article May 14

Analysts Have Made A Financial Statement On RadNet, Inc.'s (NASDAQ:RDNT) First-Quarter Report

Last week, you might have seen that RadNet, Inc. ( NASDAQ:RDNT ) released its quarterly result to the market. The early...

Recent updates

No updates